Evidence map›Paper›PMID 35835994›Full record

ArticleNature biomedical engineering2022

Multiscale optical and optoacoustic imaging of amyloid-β deposits in mice.

Ruiqing Ni, Zhenyue Chen, Xosé Luís Deán-Ben, Fabian F Voigt, Daniel Kirschenbaum, Gloria Shi, Alessia Villois, Quanyu Zhou, Alessandro Crimi, Paolo Arosio and 6 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature biomedical engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Preclinical in-vivo cerebrovascular imaging in rodent models: Methods and applications in Alzheimer's disease.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Ruiqing Ni *Institute for Biomedical Engineering, University of Zurich and ETH Zurich, Zurich, Switzerland.ORCID 0000-0002-0793-2113
Zhenyue Chen *Institute for Biomedical Engineering, University of Zurich and ETH Zurich, Zurich, Switzerland.
Xosé Luís Deán-Ben *Institute for Biomedical Engineering, University of Zurich and ETH Zurich, Zurich, Switzerland.ORCID 0000-0002-8557-7778
Fabian F VoigtZurich Neuroscience Center (ZNZ), University of Zurich and ETH Zurich, Zurich, Switzerland.
Daniel KirschenbaumInstitute of Neuropathology, Universitätsspital Zurich, Zurich, Switzerland.
Gloria ShiInstitute for Biomedical Engineering, University of Zurich and ETH Zurich, Zurich, Switzerland.
Alessia VilloisDepartment of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland.
Quanyu ZhouInstitute for Biomedical Engineering, University of Zurich and ETH Zurich, Zurich, Switzerland.ORCID 0000-0001-7719-4649
Alessandro CrimiInstitute of Neuropathology, Universitätsspital Zurich, Zurich, Switzerland.
Paolo ArosioDepartment of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland.
Roger M NitschZurich Neuroscience Center (ZNZ), University of Zurich and ETH Zurich, Zurich, Switzerland.
K Peter R NilssonDivision of Chemistry, Department of Physics, Chemistry and Biology, Linköping University, Linköping, Sweden.
Adriano AguzziZurich Neuroscience Center (ZNZ), University of Zurich and ETH Zurich, Zurich, Switzerland.ORCID 0000-0002-0344-6708
Fritjof HelmchenZurich Neuroscience Center (ZNZ), University of Zurich and ETH Zurich, Zurich, Switzerland.ORCID 0000-0002-8867-9569
Jan KlohsInstitute for Biomedical Engineering, University of Zurich and ETH Zurich, Zurich, Switzerland. klohs@biomed.ee.ethz.ch.ORCID 0000-0003-4065-2807
Daniel RazanskyInstitute for Biomedical Engineering, University of Zurich and ETH Zurich, Zurich, Switzerland. daniel.razansky@uzh.ch.ORCID 0000-0001-8676-0964
University of Zurich · CHETH Zurich · CHUniversity Hospital of Zurich · CHLinköping University · SE

Funding

Bidirectional optical-acoustic mesoscopic neural interface for image-guided neuromodulation in behaving animalsUF1NS107680 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RAZANSKY, DANIEL, RINBERG, DMITRY · 2018 to 2020
$3.4M
NINDS NIH HHS UF1 NS107680
6 · The paper itself

Abstract

Deposits of amyloid-β (Aβ) in the brains of rodents can be analysed by invasive intravital microscopy on a submillimetre scale, or via whole-brain images from modalities lacking the resolution or molecular specificity to accurately characterize Aβ pathologies. Here we show that large-field multifocal illumination fluorescence microscopy and panoramic volumetric multispectral optoacoustic tomography can be combined to longitudinally assess Aβ deposits in transgenic mouse models of Alzheimer's disease. We used fluorescent Aβ-targeted probes (the luminescent conjugated oligothiophene HS-169 and the oxazine-derivative AOI987) to transcranially detect Aβ deposits in the cortex of APP/PS1 and arcAβ mice with single-plaque resolution (8 μm) and across the whole brain (including the hippocampus and the thalamus, which are inaccessible by conventional intravital microscopy) at sub-150 μm resolutions. Two-photon microscopy, light-sheet microscopy and immunohistochemistry of brain-tissue sections confirmed the specificity and regional distributions of the deposits. High-resolution multiscale optical and optoacoustic imaging of Aβ deposits across the entire brain in rodents thus facilitates the in vivo study of Aβ accumulation by brain region and by animal age and strain.

Indexed as

Amyloid beta-PeptidesPlaque, AmyloidAnimalsDisease Models, AnimalMiceMice, TransgenicOxazinesAmyloid beta-PeptidesOxazines

Identifiers

PMID35835994
OpenAlexW4285387429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.